Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Caraco Pharmaceutical Laboratories, which manufactures, markets and distributes generic and private-label pharmaceuticals, has launched divalproex sodium delayed release tablets.
Subscribe to our email newsletter
These generic versions of divalproex sodium delayed release 125mg, 250mg, and 500mg (valproic acid activity) tablets are bioequivalent to Depakote delayed release tablets distributed by Abbott Laboratories.
Divalproex sodium delayed release tablets are indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures, as sole and adjunct therapy for patients with simple and complex absence seizures, for the treatment of the manic episodes associated with bipolar disorders, as well as for prophylaxis of migraine headaches.
Sun Pharma has recently received approval from the FDA for its abbreviated new drug application for generic Depakote delayed release tablets.